Examkin

Question

Difficulty: MediumGynecologic Infections

Correlate the following clinical assessments and microscopic laboratory findings with the correct definitive pharmacotherapy and partner management protocol.

  • A patient presents with thin, homogeneous gray vaginal discharge. An amine odor is noted upon the addition of 10% potassium hydroxide to the fluid. Microscopy demonstrates squamous epithelial cells with stippled appearances and obscured borders.Administer oral or topical metronidazole; partner treatment is generally unnecessary.
  • A patient reports dysuria alongside copious, frothy, yellow-green vaginal discharge. Speculum examination highlights vulvovaginal erythema and punctate macular hemorrhages on the cervix. A wet mount preparation shows motile, flagellated organisms.Administer a single-dose or multi-day course of oral metronidazole; concurrent therapy for sexual partner(s) is required.
  • A patient complains of severe vaginal itching and dyspareunia. Examination reveals significant vulvar edema, excoriations, and adherent, thick, cottage cheese-like discharge. A potassium hydroxide preparation shows budding yeast and pseudohyphae.Administer oral fluconazole or a topical azole; partner treatment is generally unnecessary.
  • A patient is evaluated for intermenstrual spotting and dyspareunia. Examination reveals a mucopurulent cervical exudate and a friable cervix that bleeds easily on contact with a cotton swab. A saline wet mount shows >10 polymorphonuclear leukocytes per high-power field.Administer intramuscular ceftriaxone and oral doxycycline; ensure partner evaluation and treatment.

Answer

Bacterial vaginosis is treated with metronidazole without partner treatment. Trichomoniasis requires metronidazole for the patient and all partners. Vulvovaginal candidiasis is treated with fluconazole or topical azoles without partner treatment. Cervicitis requires empiric treatment with ceftriaxone and doxycycline along with partner management.
Each clinical presentation contains classic diagnostic hallmarks for specific gynecologic infections. Management requires selecting the correct antimicrobial and correctly categorizing the disease as an STI requiring partner therapy (Trichomoniasis, Cervicitis) or a flora imbalance not requiring partner therapy (Bacterial Vaginosis, Candida).

Step-by-Step Solution

1
Evaluate the first presentation.
Identified as bacterial vaginosis due to clue cells and positive amine test.
Accurate diagnosis dictates antimicrobial choice and partner management.
2
Determine the optimal management for bacterial vaginosis.
Topical or oral metronidazole without partner therapy.
Bacterial vaginosis represents a dysbiosis of normal flora, not a sexually transmitted infection.
3
Evaluate the second presentation.
Identified as trichomoniasis due to frothy discharge, strawberry cervix, and motile protozoa.
Identifying the causative flagellated protozoan confirms Trichomonas vaginalis.
4
Determine the optimal management for trichomoniasis.
Systemic oral metronidazole with mandatory partner therapy.
Topical treatments fail to clear the organism from the urethra and Skene glands. Partner treatment prevents the ping-pong effect of reinfection.
5
Evaluate the third presentation.
Identified as vulvovaginal candidiasis due to thick, curdy discharge and pseudohyphae.
Potassium hydroxide destroys cellular elements, allowing direct visualization of fungal elements.
6
Determine the optimal management for candidiasis.
Oral fluconazole or topical azoles without partner therapy.
Candida is part of normal flora; partner transmission is not the primary cause of recurrent vaginitis.
7
Evaluate the fourth presentation.
Identified as acute cervicitis due to mucopurulent discharge, cervical friability, and abundant neutrophils on wet mount.
Inflammation localized to the cervix without a vaginitis etiology points to Chlamydia or Gonorrhea.
8
Determine the optimal management for acute cervicitis.
Empiric intramuscular ceftriaxone plus oral doxycycline with partner evaluation.
Due to high complication rates (PID) and frequent coinfection, dual coverage for N. gonorrhoeae and C. trachomatis is standard.

Key Concept

Accurate identification of gynecologic infections utilizing microscopic findings is essential to determine specific antimicrobial therapy and to establish the necessity of sexual partner treatment.
Estimated Time:2m 0s
Rate this question

Topics

Gynecologic Infections

More questions from this topic